Patents-Review.com
🔗 Permalink
Assignee profile:

NEWRON PHARMACEUTICALS S.P.A.

City:

Bresso (MI)

Country:

Italy

Published Applications:

13

Last publication date:

2017-02-02

Patent Grants:

8

Last grant date:

2018-01-02

Top Inventors for applications by NEWRON PHARMACEUTICALS S.P.A.

These are the the leading inventors for applications assigned to NEWRON PHARMACEUTICALS S.P.A.:

Recent patent applications by NEWRON PHARMACEUTICALS S.P.A.

NEWRON PHARMACEUTICALS S.P.A. based in Bresso (MI), IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-02-02 ✅ Patent 9,856,207 granted on 2018-01-02
US20170029365A1
Chemistry; metallurgy

Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects

 #2 | 2014-03-27 ✅ Patent 9,447,029 granted on 2016-09-20
US20140088074A1
Chemistry; metallurgy

Fluorinated arylalkylaminocarboxamide derivatives

 #3 | 2013-02-14 ✅ Patent 9,505,708 granted on 2016-11-29
US20130039983A1
Chemistry; metallurgy

Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects

 #4 | 2012-08-30 ✅ Patent 8,470,877 granted on 2013-06-25
US20120220592A1
Chemistry; metallurgy

2-phenylethylamino derivatives as calcium and/or sodium channel modulators

 #5 | 2012-06-07 ✅ Patent 8,710,040 granted on 2014-04-29
US20120142777A1
Human necessities

Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use

 #6 | 2011-07-28
US20110184068A1
Chemistry; metallurgy

USE OF (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDES FOR THE MANUFACTURE OF MEDICAMENTS ACTIVE AS SODIUM AND/OR CALCIUM CHANNEL SELECTIVE MODULATORS

 #7 | 2011-02-24 ✅ Patent 8,129,427 granted on 2012-03-06
US20110046129A1
Chemistry; metallurgy

2-phenylethylamino derivatives as calcium and/or sodium channel modulators

 #8 | 2010-10-21
US20100267835A1
Human necessities

Methods of treating disorders of trigeminalvascular activation

 #9 | 2010-01-21
US20100016440A1
Human necessities

ALPHA-AMINOAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS

 #10 | 2010-01-21 ✅ Patent 8,741,957 granted on 2014-06-03
US20100016437A1
Human necessities

Alpha-aminoamide derivatives useful in the treatment of cognitive disorders

 #11 | 2009-01-01
US20090005436A1
Chemistry; metallurgy

Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives

 #12 | 2008-04-24
US20080096965A1
Chemistry; metallurgy

(Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators

 #13 | 2006-04-13 ✅ Patent 7,709,523 granted on 2010-05-04
US20060079570A1
Human necessities

Alpha-aminoamide derivatives useful as antimigraine agents

Also check out Newron Pharmaceuticals, S.P.A.'s (Bresso (MI), Italy) applicant profile with 1 patent applications submitted.

AssigneeID:

9319 ⎘